Dr. Howard Smith Oncall

  Vidcast:  https://youtu.be/dkHn_fpPuPQ   The non-drowsy allergy drugs Clarinex and Claritin improve survival after treatments for melanoma and may reduce the risk of developing new melanomas.  Sweden’s Lund University analyzed 1253 melanoma patients who were anti-histamine users.   Survival was 46-50% better for those patients using Clarinex, Claritin, or generics particularly in those 65 years and older.  Use of these drugs was also associated with a 20% lower risk of a secondary melanoma though the limited numbers of cases prevented statistical significance.   If you’re in an older age group and have melanoma, regular use of prescription Clarinex or over-the-counter Claritin and their generics should be discussed with your own doctor.   https://onlinelibrary.wiley.com/doi/abs/10.1111/all.14273   #melanoma #claritin #desloratidine #loratidine